A 3-week winning streak for equities came to an end for the S&P 500 (SPX) this past week. April is generally one of the best performing months of the year, but it’s reasonable to suggest that investors are now more heavily considering the latest message from Fed Presidents and the recent FOMC minutes. The message is aptly described as possibly…
TINA Is Being Voted Out During The Midterm Year
A financial market resource for the every-day investor and trader.
-
Weekly State of the Market: Yield Boon, Tech/Growth Swoon
Seth Golden, , Research Reports, 0
“In this business, if you’re good, you’re right six times out of ten. You’re never going to be right...
-
KKR’s 2023 Outlook
Seth Golden, , Research Reports, 0
Despite all the uncertainty across today’s global capital markets, we are poised to enter 2023 with a more constructive...
-
Trade & Policy Turn Ugly & Markets Follow
Seth Golden, , Research Reports, 0
Given the state of macro-affairs that are bleeding into the market outlook, this week’s Research Report will discuss the...
-
2022: Year In Review
Seth Golden, , Research Reports, 0
by Barry Napp Our 2022 outlook note was titled Inflation Politics & Policy and began with a section titled “liquidity...
-
The Volatility Clouds Have Begun To Darken
Seth Golden, , Research Reports, 0
Posted on August 6, 2018 by Andrew Thrasher, CMT I’ve spent a great of time looking at and...
-
Be Careful With A Long VIX Strategy
Seth Golden, , Research Reports, 0
Three trading weeks have been logged in the New Year and with that… still no signs of increasing volatility...
-
Fundstrat: Risk On To 4,500
Seth Golden, , Research Reports, 0
STRATEGY: July/August “chop” morphing into full Missouri (aka “show me state”) –> tilting us further into “risk-on” view –>...
-
Bed Bath & Beyond Gross Margin Contraction Seems Never Ending
Seth Golden, , Research Reports, 0
While Bed Bath & Beyond (BBBY ) is not in dire straits, the company’s consistent underperformance over the last couple of years...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00